๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—† A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—†
Markets ยท 15 min delay
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
ISEQ9,241.3โ–ฒ +0.62%
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
Updated 04 Jul 2026 ยท HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market โ€” 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
371 medicines starting with โ€œVโ€
MedicineActive substanceLicence holderStatus
Vedixal 37.5mg Tablets
PA0711/161/002
Venlafaxine Rowex Ltd Marketed
Vedixal 75mg Tablets
PA0711/161/004
Venlafaxine Rowex Ltd Marketed
Vedixal XL 150mg Prolonged release capsules, hard
PA1445/016/002
Venlafaxine Aurobindo Pharma (Malta) Limited Marketed
Vedixal XL 75 mg prolonged release capsules, hard
PA1445/016/001
Venlafaxine Aurobindo Pharma (Malta) Limited Marketed
Vedrop 50 mg/ml Oral solution
EU/1/09/533/1-3
Tocofersolan d-alpha tocopheryl polyethylene glycol 1000 succinate Recordati Rare Diseases โ€”
Veganin Plus Tablets
PA1186/006/001
Paracetamol, Caffeine, Codeine phosphate hemihydrate Chefaro Ireland DAC Not marketed
Vegzelma 25 mg/mL concentrate for solution for infusion
EU/1/22/1667/001-004
Bevacizumab Celltrion Healthcare Hungary Kft. โ€”
Veklury 100 mg powder for concentrate for solution for infusion
EU/1/20/1459/001
Remdesivir Gilead Sciences Ireland UC โ€”
Velcade 1 mg powder for solution for injection
EU/1/04/274/002
Ps-341 as boronic acid (bortezomib) Janssen-Cilag International NV โ€”
Velcade 3.5 mg powder for solution for injection
EU/1/04/274/001
Bortezomib Janssen-Cilag International NV โ€”
Veletri 0.5 Milligram Powder for Solution for Infusion
PA0885/001/001
EPOPROSTENOL SODIUM Janssen-Cilag International NV Marketed
Veletri 1.5 Milligram Powder for Solution for Infusion
PA0885/001/002
EPOPROSTENOL SODIUM Janssen-Cilag International NV Marketed
Velmetia 50 mg/1000 mg film-coated tablets
EU/1/08/456/8-14
Sitagliptin phosphate, Metformin Hydrochloride Merck Sharp & Dohme BV โ€”
Velmetia 50 mg/850 mg film-coated tablets
EU/1/08/456/1-7
Sitagliptin phosphate, Metformin Hydrochloride Merck Sharp & Dohme BV, โ€”
Velphoro 125 mg oral powder in sachet
EU/1/14/943/005
Sucroferric Oxyhydroxide Vifor Fresenius Medical Care Renal Pharma France โ€”
Velphoro 500 mg chewable tablets
EU/1/14/943/001-004
Mixture of iron(iii)-oxyhydroxide, sucrose, starches Vifor Fresenuis Medical Care Renal Pharma France โ€”
Velsipity 2 mg film-coated tablets
EU/1/23/1790/001-003
Etrasimod arginine Pfizer Europe MA EEIG โ€”
Veltassa 1 g powder for oral suspension
EU/1/17/1179/011
Patiromer sorbitex calcium Vifor Fresenius Medical Care Renal Pharma France โ€”
Veltassa 16.8 g powder for oral suspension
EU/1/17/1179/004-006
Patiromer sorbitex calcium Vifor Fresenius Medical Care Renal Pharma France โ€”
Veltassa 25.2 g powder for oral suspension
EU/1/17/1179/007-008
Patiromer sorbitex calcium Vifor Fresenius Medical Care Renal Pharma France โ€”
Veltassa 8.4 g powder for oral suspension
EU/1/17/1179/001-003
Patiromer sorbitex calcium Vifor Fresenius Medical Care Renal Pharma France โ€”
Vemlidy 25 mg film-coated tablets
EU/1/16/1154/001-002
Tenofovir alafenamide Gilead Sciences Ireland UC โ€”
Venaforce Varicose Veins gastro-resistant tablets
TR2309/011/001
A.Vogel Ireland Limited Marketed
Venclyxto 10 mg film-coated tablets
EU/1/16/1138/001-002
Venetoclax AbbVie Deutschland GmbH & Co. KG โ€”
Venclyxto 100 mg film-coated tablets
EU/1/16/1138/005-007
Venetoclax AbbVie Deutschland GmbH & Co. KG โ€”
Venclyxto 50 mg film-coated tablets
EU/1/16/1138/003-004
Venetoclax AbbVie Deutschland GmbH & Co. KG โ€”
Venex XL 150 mg Prolonged-release Capsules, hard
PA0126/285/003
Venlafaxine hydrochloride Clonmel Healthcare Ltd Marketed
Venex XL 37.5 mg Prolonged-release Capsules, hard
PA0126/285/001
Venlafaxine hydrochloride Clonmel Healthcare Ltd Marketed
Venex XL 75 mg prolonged-release capsules, hard
PA0126/285/002
Venlafaxine hydrochloride Clonmel Healthcare Ltd Marketed
Venlablue XL 150mg Prolonged Release Capsules, Hard
PA1436/006/002
Venlafaxine Bluefish Pharmaceuticals AB Marketed
Venlablue XL 75 mg prolonged-release capsules, hard
PA1436/006/001
Venlafaxine Bluefish Pharmaceuticals AB Marketed
Venlafex XL 150 mg prolonged-release capsules, hard
PA1347/036/003
Venlafaxine hydrochloride KRKA, d.d., Novo mesto Marketed
Venlafex XL 37.5 mg prolonged-release capsules, hard
PA1347/036/001
Venlafaxine hydrochloride KRKA, d.d., Novo mesto Marketed
Venlafex XL 75 mg prolonged-release capsules, hard
PA1347/036/002
Venlafaxine hydrochloride KRKA, d.d., Novo mesto Marketed
Venlatev 150 mg hard prolonged-release capsules
PA1986/099/003
Venlafaxine Teva B.V. Marketed
Venlatev 37.5 mg hard prolonged-release capsules
PA1986/099/001
Venlafaxine Teva B.V. Marketed
Venlatev 75 mg hard prolonged-release capsules
PA1986/099/002
Venlafaxine Teva B.V. Marketed
Venlofex 150 mg prolonged-release hard capsules
PA23266/049/002
Venlafaxine hydrochloride Viatris Limited Marketed
Venlofex 75 mg prolonged-release hard capsules
PA23266/049/001
Venlafaxine hydrochloride Viatris Limited Marketed
Venofer 20 mg iron/mL solution for injection or concentrate for solution for infusion, ampoule
PA0949/001/001
IRON (III) Vifor France Not marketed
Venofer 20 mg iron/mL solution for injection or concentrate for solution for infusion, vial
PA0949/001/002
Iron (iii) - hydroxide sucrose complex Vifor France Marketed
Vensir XL 150 mg prolonged-release hard capsules
PA23142/002/002
Venlafaxine Aspire Pharma (Malta) Limited Not marketed
Vensir XL 75 mg prolonged-release hard capsules
PA23142/002/001
Venlafaxine hydrochloride Aspire Pharma (Malta) Limited Not marketed
Ventavis 10 microgram/ml nebuliser solution
EU/1/03/255/1-3
Iloprost trometanol Bayer AG โ€”
Ventavis 20 microgram/ml nebuliser solution
EU/1/03/255/009-010,012
Iloprost trometanol Bayer Pharma AG โ€”
Ventizolve 1.26 mg nasal spray, solution in single-dose container
PA1270/002/001
Naloxone Navamedic ASA Marketed
Ventolin 1mg/ml Concentrate for Solution for Intravenous Infusion
PA1077/049/002
Salbutamol GlaxoSmithKline (Ireland) Limited Marketed
Ventolin 2mg/5ml Oral Solution
PA1077/049/012
SALBUTAMOL SULFATE GlaxoSmithKline (Ireland) Limited Marketed
Ventolin 500 micrograms/ml Solution for Injection
PA1077/049/001
Salbutamol GlaxoSmithKline (Ireland) Limited Marketed
Ventolin Diskus 200 micrograms Inhalation Powder, pre-dispensed
PA1077/049/011
Salbutamol GlaxoSmithKline (Ireland) Limited Marketed
โ† 1 2 3 4 5 6 โ†’

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.